Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  WuXi AppTec Co., Ltd.    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
End-of-day quote. End-of-day quote Shanghai Stock Exchange - 04/03
93.76 CNY   -0.32%
03/26Asia bankers look to follow-on deals as capital raising hits 12-year low
RE
03/24WUXI APPTEC : Plans Private Share Placement
DJ
03/20WUXI APPTEC CO., LTD. : annual earnings release
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
03/30/2020 03/31/2020 04/01/2020 04/02/2020 04/03/2020 Date
87.5 90.49 90.5 94.06 93.76 Last
24837150 15447790 11649600 11063520 9909110 Volume
-6.22% +3.42% +0.01% +3.93% -0.32% Change
Financials (CNY)
Sales 2020 16 156 M
EBIT 2020 3 282 M
Net income 2020 2 559 M
Finance 2020 2 214 M
Yield 2020 0,51%
Sales 2021 20 418 M
EBIT 2021 4 329 M
Net income 2021 3 482 M
Finance 2021 5 613 M
Yield 2021 0,69%
P/E ratio 2020 60,7x
P/E ratio 2021 44,4x
EV / Sales2020 9,39x
EV / Sales2021 7,27x
Capitalization 154 B
More Financials
Company
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as... 
More about the company
Surperformance© ratings of WuXi AppTec Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on WUXI APPTEC CO., LTD.
03/26Asia bankers look to follow-on deals as capital raising hits 12-year low
RE
03/24WUXI APPTEC : Plans Private Share Placement
DJ
03/20WUXI APPTEC CO., LTD. : annual earnings release
01/03WUXI APPTEC : STA Pharmaceutical - WuXi STA Opens Oligonucleotide Large-Scale Ma..
AQ
2019WUXI APPTEC : ATU and GeneMedicine Sign Development and Manufacturing Agreement ..
AQ
2019China's major shareholders sell A-shares, pressuring markets
RE
2019WUXI APPTEC : 1) adjustments to the number of the incentive participants and num..
PU
2019WUXI APPTEC : Inside information - proposed disposal of a shares by shareholders
PU
2019WUXI APPTEC : Lab Testing Division Expands Toxicology Facility in Suzhou, China
AQ
2019WUXI APPTEC : Dr. Ge Li Awarded 'CEO of the Year' at CPhI Worldwide 2019
AQ
2019WUXI APPTEC : Receives Investment Grade Corporate Ratings from Three Global Rati..
AQ
2019WUXI APPTEC : Reports Third-Quarter 2019 Results
AQ
2019WUXI APPTEC : Indicative announcement regarding the third h share class meeting
PU
2019WUXI APPTEC : STA's Jinshan Facility Passes EMA Inspection
AQ
2019WUXI APPTEC : Supplemental announcement in relation to the annual report for the..
PU
More news
News in other languages on WUXI APPTEC CO., LTD.
03/20WUXI APPTEC CO., LTD. : publication des résultats annuels
03/20WUXI APPTEC CO., LTD. : Veröffentlichung des Jahresergebnisses
2018Hong Kong parti pour être en tête du classement des IPO en 2018
2018Fosun Tourism (Club Med) lève 428 millions de dollars lors de son IPO à Hong ..
More news
Chart WUXI APPTEC CO., LTD.
Duration : Period :
WuXi AppTec Co., Ltd. Technical Analysis Chart | 603259 | CNE1000031K4 | MarketScreener
Technical analysis trends WUXI APPTEC CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Average target price 112,36  CNY
Last Close Price 93,76  CNY
Spread / Highest target 47,5%
Spread / Average Target 19,8%
Spread / Lowest Target -17,4%
EPS Revisions
Managers
NameTitle
Edward Hu Co-Chief Executive Officer, CIO & Director
Ge Li Chairman, President & Co-Chief Executive Officer
Harry He Chairman-Supervisory Board
Guo Dong Tong Chief Operating Officer & Senior Vice President
Ellis Chu Chief Financial Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
WUXI APPTEC CO., LTD.-0.12%21 017
GILEAD SCIENCES19.62%94 124
VERTEX PHARMACEUTICALS16.60%61 693
REGENERON PHARMACEUTICALS34.30%53 154
BIONTECH SE55.64%13 733
GENMAB A/S-1.45%13 229